Drug Search Results
More Filters [+]

Delmitide

Alternative Names: delmitide
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Immunosuppressive Immuno

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Procter and Gamble
Company Location: CINCINNATI OH 45202
Company CEO: Jon R. Moeller
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Delmitide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title